FBXO22 and lung carcinoma: Intriguingly, the ectopically expressed FBXO22 did not cause apparent change in cell proliferation in LKB1-deficient lung cancer cells, but could dramatically rescue LKB1-mediate cell growth inhibition in LKB1 expressed lung cancer cells (Fig. 6a, b, d).